Enjoy complimentary customisation on priority with our Enterprise License!
The global upper respiratory tract infection treatment market size is estimated to grow by USD 2.66 billion at a CAGR of 4.21% between 2023 and 2028.
Top players in the market would be encouraged to concentrate on developing respiratory drugs that treat upper tract infections given the high prevalence of these infections. In the pipeline, a number of late-stage molecules are likely to be launched over the next few years. For instance, Emergo Therapeutics is developing norketotifen, an antagonist of the histamine H1 receptor and mast stabilizer, to treat allergic rhinitis. The drug is currently in a Phase II clinical trial. Hence, such a favorable drug pipeline will boost the growth of the market growth during the forecast period.
To learn more about this report, Request Free Sample
Technavio has segmented the market into Type, Distribution Channel, and Application
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 to 2022, besides analyzing the current market scenario.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.